Washington bills · 2025-2026 Regular Session
Washington HB 1425
Requiring coverage of pharmacogenomic testing for psychotropic medications.
- Introduced
- In committee
- Passed House
- Passed Senate
- To Governor
- Became law
Sponsors
- Davis (Democratic)
Cosponsors (11)
- Ormsby (Democratic)
- Doglio (Democratic)
- Gregerson (Democratic)
- Berry (Democratic)
- Simmons (Democratic)
- Tharinger (Democratic)
- Macri (Democratic)
- Parshley (Democratic)
- Stonier (Democratic)
- Rule (Democratic)
- Obras (Democratic)
Summary
No official summary is available for this bill.
Latest action(Jan 12, 2026): By resolution, reintroduced and retained in present status.
Text versions
Roll-call votes
No recorded votes on this bill.
Actions
- Jan 12, 2026 · House
By resolution, reintroduced and retained in present status. - Feb 4, 2025 · House
Public hearing in the House Committee on Health Care & Wellness at 1:30 PM. - Jan 20, 2025 · House
First reading, referred to Health Care & Wellness.